Victory Capital Management Inc. Has $3.75 Million Stake in Oscar Health, Inc. (NYSE:OSCR)

Key Points

• Victory Capital Management Inc. increased its stake in Oscar Health, Inc. by 23.8%, acquiring an additional 54,938 shares, bringing its total holdings to 285,997 shares worth approximately $3.75 million.
• Several analysts have downgraded their ratings for Oscar Health, with Baird R W reflecting a significant cut from a "strong-buy" to a "hold" rating, and a consensus price target now set at $12.21.
• Oscar Health reported a 42.2% increase in revenue year-over-year, achieving $3 billion for the latest quarter and exceeding analyst expectations.

Victory Capital Management Inc. raised its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 23.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 285,997 shares of the company's stock after acquiring an additional 54,938 shares during the quarter. Victory Capital Management Inc. owned approximately 0.11% of Oscar Health worth $3,749,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Larson Financial Group LLC lifted its holdings in shares of Oscar Health by 83,733.3% during the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock valued at $33,000 after buying an additional 2,512 shares during the last quarter. CWM LLC lifted its holdings in shares of Oscar Health by 50.7% during the 1st quarter. CWM LLC now owns 3,204 shares of the company's stock valued at $42,000 after buying an additional 1,078 shares during the last quarter. Princeton Global Asset Management LLC acquired a new stake in shares of Oscar Health during the 1st quarter valued at about $59,000. GAMMA Investing LLC lifted its holdings in shares of Oscar Health by 2,156.4% during the 1st quarter. GAMMA Investing LLC now owns 6,476 shares of the company's stock valued at $85,000 after buying an additional 6,189 shares during the last quarter. Finally, Tower Research Capital LLC TRC lifted its holdings in shares of Oscar Health by 171.4% during the 4th quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company's stock valued at $89,000 after buying an additional 4,185 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company's stock.

Oscar Health Stock Performance

Shares of OSCR stock traded up $0.29 during trading hours on Thursday, reaching $14.29. 7,668,884 shares of the company's stock were exchanged, compared to its average volume of 12,819,970. Oscar Health, Inc. has a fifty-two week low of $11.20 and a fifty-two week high of $23.79. The stock has a market capitalization of $3.64 billion, a P/E ratio of 51.01 and a beta of 1.90. The business has a fifty day moving average price of $15.88 and a 200-day moving average price of $14.91. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.22.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, topping analysts' consensus estimates of $0.83 by $0.09. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The company had revenue of $3 billion during the quarter, compared to analyst estimates of $2.87 billion. During the same period in the previous year, the company earned $0.62 earnings per share. The company's quarterly revenue was up 42.2% compared to the same quarter last year. Analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on OSCR. Barclays reduced their price target on Oscar Health from $17.00 to $11.00 and set an "underweight" rating for the company in a report on Wednesday, July 23rd. Baird R W lowered Oscar Health from a "strong-buy" rating to a "hold" rating in a report on Friday, July 25th. UBS Group restated a "sell" rating and issued a $11.00 target price (down from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Raymond James Financial lowered Oscar Health from an "outperform" rating to a "market perform" rating in a report on Tuesday, June 24th. Finally, Wells Fargo & Company lowered Oscar Health from an "equal weight" rating to an "underweight" rating and reduced their target price for the stock from $16.00 to $10.00 in a report on Friday, July 11th. Five equities research analysts have rated the stock with a sell rating and five have given a hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $12.21.

Insider Activity at Oscar Health

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the completion of the transaction, the director directly owned 64,512 shares in the company, valued at approximately $1,059,932.16. This represents a 27.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 24.39% of the stock is currently owned by company insiders.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.